Zai Lab Valuation
| ZLAB Stock | USD 33.91 0.96 2.91% |
At this time, the company appears to be overvalued. Zai Lab maintains a prevalent Real Value of $26.46 per share. The last-minute price of the company is $33.91. Our model calculates the value of Zai Lab from examining the company fundamentals such as Profit Margin of (0.76) %, return on asset of -0.21, and Current Valuation of 3.25 B as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Zai Lab's price fluctuation is not too volatile at this time. Calculation of the real value of Zai Lab is based on 3 months time horizon. Increasing Zai Lab's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Zai Lab is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Zai Stock. However, Zai Lab's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 33.91 | Real 26.46 | Hype 33.91 | Naive 35.66 |
The real value of Zai Stock, also known as its intrinsic value, is the underlying worth of Zai Lab Company, which is reflected in its stock price. It is based on Zai Lab's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Zai Lab's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Zai Lab helps investors to forecast how Zai stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Zai Lab more accurately as focusing exclusively on Zai Lab's fundamentals will not take into account other important factors: Zai Lab Total Value Analysis
Zai Lab is at this time forecasted to have valuation of 3.25 B with market capitalization of 3.65 B, debt of 15.15 M, and cash on hands of 1.26 B. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Zai Lab fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.25 B | 3.65 B | 15.15 M | 1.26 B |
Zai Lab Investor Information
About 54.0% of the company outstanding shares are owned by institutional investors. The company recorded a loss per share of 2.8. Zai Lab had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Zai Lab's historical financial statements, Zai Lab is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March.Zai Lab Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Zai Lab has an asset utilization ratio of 25.74 percent. This suggests that the Company is making $0.26 for each dollar of assets. An increasing asset utilization means that Zai Lab is more efficient with each dollar of assets it utilizes for everyday operations.Zai Lab Ownership Allocation
Zai Lab retains a total of 108.94 Million outstanding shares. Over half of Zai Lab's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.Zai Lab Profitability Analysis
The company reported the previous year's revenue of 266.72 M. Net Loss for the year was (334.62 M) with loss before overhead, payroll, taxes, and interest of (39.46 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Zai Lab's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Zai Lab and how it compares across the competition.
About Zai Lab Valuation
The stock valuation mechanism determines Zai Lab's current worth on a weekly basis. Our valuation model uses a comparative analysis of Zai Lab. We calculate exposure to Zai Lab's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Zai Lab's related companies.Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. Zai Lab Limited was incorporated in 2013 and is headquartered in Shanghai, China. Zai Lab operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1951 people.
Zai Lab Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 966.4 M |
Complementary Tools for Zai Stock analysis
When running Zai Lab's price analysis, check to measure Zai Lab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zai Lab is operating at the current time. Most of Zai Lab's value examination focuses on studying past and present price action to predict the probability of Zai Lab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zai Lab's price. Additionally, you may evaluate how the addition of Zai Lab to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |